Institutional review board (IRB) services
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00297
- Awardee
-
Advarra, Inc. UEI GEGFK6SM8RM3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $194,900
Award facts
- Opportunity
-
- 75N92021Q0194 Solicitation number
- Contract value 100% obligated
- $194,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21046, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20 | |
| Exercise an Option | $25,000 | |
| Exercise an Option | $55,010 | |
| Additional Work (new agreement, FAR part 6 applies) | $25,045 | |
| Other Administrative Action | $29,955 | |
| Exercise an Option | $29,955 | |
| Original award | $29,955 |
About this award
The National Heart, Lung and Blood Institute (NHLBI) awarded a $194.9K firm fixed-price purchase order to Advarra, Inc. (doing business as Chesapeake IRB) for Institutional Review Board (IRB) services. The contract, which commenced on September 1, 2021 and runs through August 31, 2026, will be performed in Columbia, Maryland. This award carries no set-aside designation, meaning Advarra competed for the contract in the open market. Advarra specializes in providing comprehensive IRB services and human subjects protection support to federal agencies and research institutions, ensuring that federally funded research adheres to ethical standards and regulatory compliance requirements.
As an established IRB service provider across multiple National Institutes of Health components, Advarra brings substantial expertise to this engagement with NHLBI. The company currently holds an Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID) valued at nearly $14M extending through 2031, demonstrating its capacity to manage large-scale, complex IRB oversight activities. Under the NHLBI contract, Advarra will deliver protocol review, study conduct oversight, findings communication, and regulatory compliance monitoring for human subjects research. This engagement supports NHLBI's mission to advance cardiovascular, pulmonary, and blood disease research while maintaining the highest standards of research ethics and participant protection.
Quick answers
Who was awarded contract 75N92021P00297?
75N92021P00297 was awarded to Advarra, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2021.
How much is contract 75N92021P00297 worth?
The government has obligated $194,900 on 75N92021P00297.
Was contract 75N92021P00297 competed?
The extent of competition for 75N92021P00297 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award